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Hyperdynamic circulation observed in portal hyperten-
sion is characterized by pronounced vasodilatation,
increased systemic and regional blood flows, and aug-
mented cardiac index. Drugs used for the treatment
of portal hypertension, such as β-adrenergic blocking
agents, have also proved useful in controlling the car-
diovascular manifestations of thyrotoxicosis. Moreover,
propylthiouracil, a commonly used drug for the treat-
ment of hyperthyroidism, has been used for the man-
agement of patients with alcoholic liver disease with
favorable response.1 In a rat model of portal vein liga-
tion, hypothyroidism caused amelioration of the hyper-
dynamic circulation followed by reduction of the portal
pressure.2 Therefore, alleviation of the hypermetabolic
state by thyroid hormone manipulation might be a
treatment option for the hyperdynamic circulation
observed in the portal hypertensive state.
Besides the hemodynamic effects, data from recent
studies suggest that induced hypothyroidism prevents
the development of liver injury in several animal mod-
els. An important study by Oren et al3 investigated the
effects of experimentally induced hypo- and hyper-
thyroidism on the development of cirrhosis induced in
rats by thioacetamide (TAA). In that study, the authors
found that hepatic fibrosis was significantly reduced in
hypothyroid rats as compared with euthyroid controls,
and was aggravated in TAA-treated hyperthyroid rats.3
Later studies also confirmed that hypothyroidism can
minimize lectin concanavalin A-induced acute liver
injury4 and improve survival in TAA-induced fulmi-
nant hepatic failure.5
The study by Chang et al6 is the first to investigate
the effect of chronic thyroid hormone inhibition on
hepatic encephalopathy in bile-duct ligated cirrhotic
rats. For more accurate quantification of the degree of
hepatic encephalopathy, the authors used automated
open field boxes equipped with infrared cells to detect
the motor activities of rats. On the basis of consecu-
tive interruption of the infrared monitoring beams,
this apparatus could allow them to differentiate non-
ambulatory (scratching, gnawing) from ambulatory
movements. The additional row of infrared cells above
the plane could provide them with more information
concerning the movements in the vertical direction.
As compared with the control group, this study demon-
strated that the amount of total movements were sig-
nificantly increased in rats with hypothyroidism induced
by methimazole.6 Probably related to the small sample
size, the differences in ambulatory and vertical move-
ments between these 2 groups did not reach statistical
significance.
Regarding the impact of hypothyroidism on hepatic
damage followed by bile-duct ligation, Chang et al’s
study showed that plasma levels of ammonia, aspartate
aminotransferase and alkaline phosphatase were signif-
icantly lower in the methimazole group.6 However, the
authors did not provide the data to investigate the
possible pathogenesis of thyroid hormone manipula-
tion on hepatic damage, and this might affect the sci-
entific value of their article. Another important issue
which should be addressed here is that different doses
of methimazole might have different effects, and the
resulting consequences in cerebral and hepatic tissues
might be uneven. All the above points deserve further
investigation to justify whether or not and to what
degree thyroid hormone inhibition can be used as a
treatment option in acute or chronic liver injury and
hepatic encephalopathy.
EDITORIAL COMMENT
Is Hypothyroidism a Treatment Option in 
Conditions of Liver Injury and Hepatic
Encephalopathy?
Chi-Jen Chu*
Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, and 
National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
© 2006 Elsevier. All rights reserved.
*Correspondence to: Dr Chi-Jen Chu, Division of Gastroenterology, Department of Medicine, Taipei Veterans
General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
E-mail: cjchu@vghtpe.gov.tw ● Received: September 12, 2006 ● Accepted: October 24, 2006
J Chin Med Assoc • December 2006 • Vol 69 • No 12562
C.J. Chu
To date, the mechanisms responsible for the amelio-
ration of liver injury in rats by hypothyroidism remain
incompletely understood. However, emerging studies
have disclosed that hypothyroidism might protect the
liver by inhibiting the generation of free-oxygen radi-
cals, which might cause cell necrosis via oxidation of
cellular proteins, DNA, and lipids.7,8 Malodialdehyde,
derived from lipid peroxidation, was markedly increased
in the serum and liver of euthyroid rats treated with
TAA, but only slightly increased in hypothyroid rats
following TAA administration.5 The above findings
suggest that, probably by minimizing oxidative injury
to hepatocytes, hypothyroidism plays a protective role
in rats with fulminant hepatic failure induced by TAA.
Similar to TAA-induced fulminant hepatic failure, in a
rat model of chronic TAA ingestion,3 liver cirrhosis was
completely prevented by hypothyroidism, and experi-
mental evidence suggested that toxic oxygen species
produced by lipid peroxidation lead to chronic injury
and the development of fibrosis.9,10 In contrast, in rats
with hyperthyroidism, generalized hypermetabolism
and increased hepatocyte oxygen demand lead to an
accelerated development of TAA-induced liver cirrhosis
and portal hypertension.3 Therefore, it appears that
hypometabolism and decreased hepatocyte oxygen
demand, associated with hypothyroidism, may be pro-
tective for the insulted liver.5 This is supported by the
fact that the protective role of hypothyroidism in liver
injury can also be found in conditions other than toxic
liver injury such as immune-mediated hepatitis4 or
mechanically-induced liver damage such as portal vein
and bile-duct ligation.2,3
In addition, several lines of evidence suggest that
thyroid status may have immunomodulatory effects:
decreased thyroid function is associated with reduced
CD41 T lymphocyte activation, increased number and
activation of CD81 cells and decreased soluble inter-
leukin (IL)-2 receptors.11 In the study by Bruck et al,5
serum levels of tumor necrosis factor (TNF)-α, IL-2,
and IL-6 were measured at 2, 6, 24, and 48 hours fol-
lowing TAA administration in hypothyroid and normal
rats. The significantly lower serum levels of TNF-α and
the other cytokines in the hypothyroid as compared
with the euthyroid rats suggest that the suppression of
cytokine release might have a role in the prevention
of fulminant hepatic failure by hypothyroidism.
In conclusion, this is an interesting study demon-
strating that hypothyroidism by chronic methimazole
administration can alleviate the degree of liver injury
and hepatic encephalopathy in bile-duct ligated cirrhotic
rats. However, the underlying mechanisms responsi-
ble for this phenomenon remain incompletely under-
stood, but immunomodulation and minimization of
oxidative liver injury are possible mechanisms. Further
studies on the pathogenesis are needed to justify
whether hypothyroidism can be used as a treatment
option during conditions of liver injury and hepatic
encephalopathy.
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